Helix BioPharma (TSX:HBP) EV-to-FCF : -7.22 (As of May. 25, 2024)

Helix BioPharma EV-to-FCF Chart

Helix BioPharma Annual Data
	Trend	Jul14	Jul15	Jul16	Jul17	Jul18	Jul19	Jul20	Jul21	Jul22	Jul23
EV-to-FCF		Get a 7-Day Free Trial					-11.19	-6.30	-12.60	-4.89	-8.07

Helix BioPharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EV-to-FCF	Get a 7-Day Free Trial															-6.94	-6.82	-8.07	-7.66	-6.41

Competitive Comparison of Helix BioPharma's EV-to-FCF

For the Biotechnology subindustry, Helix BioPharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Helix BioPharma's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helix BioPharma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Helix BioPharma's EV-to-FCF falls into.

Helix BioPharma EV-to-FCF Calculation

Helix BioPharma's EV-to-FCF for today is calculated as:

Helix BioPharma's current Enterprise Value is C$46.25 Mil.
Helix BioPharma's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-6.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helix BioPharma  (TSX:HBP) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Helix BioPharma's PE Ratio for today is calculated as:

Helix BioPharma's share price for today is C$0.205.
Helix BioPharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.031.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Helix BioPharma EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Helix BioPharma (TSX:HBP) Business Description